CORONAVIRUS/COVID-19 NOTICE:

The Institute for Biohealth Innovation's (IBI's) team will continue to support the IBI community and research operations virtually. Explore COVID-19 funding and research opportunities, as well as operations and communications details surrounding the crisis.

IBI: Powering Partnerships

The Institute for Biohealth Innovation (IBI) promotes and supports biohealth-related research activities of faculty, staff, and students at George Mason University. The IBI connects Mason researchers in biohealth with potential collaborators, both within the university and externally, to advance human health research. Our world-class research community works hand-in-hand with individuals and organizations in the health and wellbeing industries to develop new technologies and interventions. We represent a melting pot of disciplines, including cancer, infectious diseases, brain and behavior, injury and performance, policy, economics, reproductive and family health, and cardiovascular and metabolic studies. 

Reducing high school #prescriptiondrugabuse through a hybrid prevention program: New program led by @MasonCHHS Dr. Kenneth W. Griffin to begin in U.S. high schools @MasonResearch @GeorgeMasonNews
https://fal.cn/38VBV

Mason researchers and Ceres Nanosciences, a company that grew from Mason, describe a method for capturing and concentrating SARS-CoV-2 in order to improve #COVID19 testing, especially when the viral load in samples is low, which could lead to fewer false negatives. #MasonResearch

Ceres Nanosciences@Nanotrap

The teams @GMU_COS and @nanotrap are excited to share our rapid and versatile method for improving detection of SARS-CoV-2.

https://bit.ly/2Zi1IBr

Home